These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32660687)

  • 1. Response of the Public to Preventive Measures of COVID-19 in Iraqi Kurdistan.
    Abdulah DM; Aziz Qazli SS; Suleman SK
    Disaster Med Public Health Prep; 2021 Oct; 15(5):e17-e25. PubMed ID: 32660687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public Opinions and Conspiracy Thinking Toward the COVID-19 Outbreak in Iraqi Kurdistan.
    Abdulah DM; Saeed MS
    Disaster Med Public Health Prep; 2022 Aug; 16(4):1322-1325. PubMed ID: 33691810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study.
    Almufty HB; Mamani MMA; Ali AH; Merza MA
    J Med Virol; 2022 Nov; 94(11):5244-5250. PubMed ID: 35811398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
    Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; von Buchwald C; Todsen T; Norsk JB; Pries-Heje MM; Vissing CR; Nielsen PB; Winsløw UC; Fogh K; Hasselbalch R; Kristensen JH; Ringgaard A; Porsborg Andersen M; Goecke NB; Trebbien R; Skovgaard K; Benfield T; Ullum H; Torp-Pedersen C; Iversen K
    Ann Intern Med; 2021 Mar; 174(3):335-343. PubMed ID: 33205991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Adenaiye OO; Lai J; Bueno de Mesquita PJ; Hong F; Youssefi S; German J; Tai SHS; Albert B; Schanz M; Weston S; Hang J; Fung C; Chung HK; Coleman KK; Sapoval N; Treangen T; Berry IM; Mullins K; Frieman M; Ma T; Milton DK
    Clin Infect Dis; 2022 Aug; 75(1):e241-e248. PubMed ID: 34519774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2.
    Ueki H; Furusawa Y; Iwatsuki-Horimoto K; Imai M; Kabata H; Nishimura H; Kawaoka Y
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome Sequencing to Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Nosocomial Outbreaks.
    Lucey M; Macori G; Mullane N; Sutton-Fitzpatrick U; Gonzalez G; Coughlan S; Purcell A; Fenelon L; Fanning S; Schaffer K
    Clin Infect Dis; 2021 Jun; 72(11):e727-e735. PubMed ID: 32954414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand.
    Doung-Ngern P; Suphanchaimat R; Panjangampatthana A; Janekrongtham C; Ruampoom D; Daochaeng N; Eungkanit N; Pisitpayat N; Srisong N; Yasopa O; Plernprom P; Promduangsi P; Kumphon P; Suangtho P; Watakulsin P; Chaiya S; Kripattanapong S; Chantian T; Bloss E; Namwat C; Limmathurotsakul D
    Emerg Infect Dis; 2020 Nov; 26(11):2607-2616. PubMed ID: 32931726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic modeling and risk assessment of aerial transmission of SARS-CoV-2 virus through vaping expirations in shared micro-environments.
    Sussman RA; Golberstein E; Polosa R
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):83020-83044. PubMed ID: 35754079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of nurses amidst giving care to COVID-19 patients in clinical settings in Iraqi Kurdistan: A qualitative descriptive study.
    Abdulah DM; Mohammedsadiq HA; Liamputtong P
    J Clin Nurs; 2022 Jan; 31(1-2):294-308. PubMed ID: 34152045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19.
    Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; Mariager AF; Schytte N; von Buchwald C; Todsen T; Skovgaard K; Trebbien R; Andersen MP; Benfield T; Ullum H; Torp-Pedersen C; Iversen K
    Dan Med J; 2020 Aug; 67(9):. PubMed ID: 32829745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.